NIH-funded research Career grant

Understanding how to protect the intestines of premature infants from injury

Official title: Regulation of signaling pathways mediating epithelial cell injury in the neonatal intestine

Funded at Univ of North Carolina Chapel Hill · NIH-11132961 · Data updated 2026-11-12

This study is looking at how certain diets and gut bacteria can help prevent serious intestinal problems in premature babies, with the hope of finding new ways to keep their tummies healthy and reduce inflammation.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJuly 15, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$174,114
NIH project number5K08DK140604-02
Project IDNIH-11132961 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are premature infants born weighing less than 1500 grams who are at risk for developing necrotizing enterocolitis.

Less likely to help

Patients who are not premature or who do not have a low birth weight may not benefit from this research.

What this research studies

This research focuses on necrotizing enterocolitis (NEC), a severe intestinal disease affecting premature infants. The study aims to uncover the signaling pathways that lead to intestinal injury and how these pathways can be influenced by dietary components and microbial metabolites. By investigating the role of specific receptors and transcription factors, the researchers hope to identify new therapeutic strategies that could improve outcomes for affected neonates. The ultimate goal is to develop dietary interventions or treatments that can reduce inflammation and protect the intestinal lining in vulnerable infants.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly reduce the incidence and severity of necrotizing enterocolitis in premature infants.

How similar studies have gone: Previous research has shown promise in understanding similar signaling pathways in other gastrointestinal conditions, suggesting potential for success in this area as well.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Frazer, Lauren Carole — Univ of North Carolina Chapel Hill
  • Study coordinator: Frazer, Lauren Carole

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.